Clinical Trial Update: The Medacta International AMIStem-P Post-Marketing Surveillance Study

View source ↗

Summary

Post-marketing surveillance study update for Medacta's AMIStem-P hip stem; the observational study is currently active but not recruiting, assessing outcomes in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avascular Necrosis of the Femoral Head
• Developmental Dysplasia of the Hip
• Osteoarthritis
• Post-traumatic Arthritis
• Rheumatoid Arthritis

Snippet

Sponsor: Medacta International SA | Conditions: Arthrosis, Traumatic Arthritis | Status: ACTIVE_NOT_RECRUITING